LeMaitre Vascular, Inc. Financials

Market Capitalization $1.91 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	42.84
Forward PE	38.89
Price to Sales TTM	$8.43
Price to Book MRQ	$5.49
Enterprise to Revenue	7.78
Enterprise to EBITDA	27.99

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	19.96%
Operating Margin	21.09%
Return on Assets TTM	7.28%
Return on Equity TTM	13.77%

Income Statement

Revenue TTM	$226,256,000
Revenue per Share TTM	$10.05
Quarterly Revenue Growth	12.00%
Gross Profit TTM	$155,656,000
EBITDA	$70,499,000
Net Income to Common TTM	$45,162,000
Diluted EPS TTM	$1.97
Quarterly Earnings Growth YoY	11.40%

Balance Sheet

Total Cash MRQ	$302,548,992
Total Cash per Share MRQ	$13.39
Total Debt MRQ	$
Total Debt to Equity MRQ	53.33
Current Ratio MRQ	16.49
Book Value per Share MRQ	$15.38

Cash Flow

Operating Cash Flow TTM	$48,092,000
Levered Free Cash Flow TTM	$29,002,624

LMAT Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	22,549,340
Float Shares	20,653,958
Avg 10 Volume	171,390
Avg 30 Volume	None
Shares Short	1,308,463
Short Ratio	7.77
Short % of Shares	7.84%
% Held by Insiders	8.83%
% Held by Institutions	94.91%

Stock Price Summary

Beta	0.82
Fifty Two Week Low	$71.42
Fifty Two Week High	$109.58
Fifty Two Week Change	1.45%
Day 50 MA	$83.69
Day 200 MA	$90.82

Dividends and Splits

Forward Annual Dividend Rate	$0.80
Forward Annual Dividend Yield	0.95%
Trailing Annual Dividend Rate	$0.72
Trailing Annual Dividend Yield	0.85%
Payout Ratio	34.52%
Dividend Date	2025-05-29
Ex Dividend Date	2025-05-15
Last Split Factor
Last Split Date